VIVO Cannabis sinks after buyout offer from MediPharm Labs
** Shares of VIVO Cannabis Inc VIVO.TO fall 16.7% to
C$0.03
** MediPharm Labs Corp LABS.TO says it will acquire VIVO
Cannabis urn:newsml:reuters.com:*:nCNWbWNT6a
** VIVO shareholders are expected to own between 35% and 21%
of the combined company
** Including session's losses, stock down 68.8% YTD
(Reporting by Sourasis Bose in Bengaluru)
((Sourasis.bose@thomsonreuters.com))
Recent news on Medipharm Labs
See all newsCanada's MediPharm Labs Q2 revenue rises 11% on international growth
Brief: MediPharm Labs Q2 Revenue CAD 10 Million
Canada's MediPharm Labs reports positive Q1 adjusted EBITDA
Canada's MediPharm Labs FY revenue rises 8% on international sales
Brief: Medipharm Labs Reports Full Year & Fourth Quarter 2025 Results With Over 40% Annual Growth In International Medical Revenue